PCRX FY 2018 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$969M

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$337M+17.7% YoY

Gross Profit

$250M74.3% margin

Operating Income

$16M4.7% margin

Net Income

-$471,000-0.1% margin

EPS (Diluted)

$-0.01

Cash Flow

Operating Cash Flow

$49M

Free Cash Flow

$34M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$689M

Total Liabilities

$368M

Stockholders' Equity

$321M

Cash & Equivalents

$133M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$337M	$287M	+17.7%
Gross Profit	$250M	$199M	+26.0%
Operating Income	$16M	-$25M	+163.8%
Net Income	-$471,000	-$43M	+98.9%